Collaboration with a leading US patient advocate is facilitating access across states, and a new clinical site in Germany will soon offer this testing. Register for updates at attomarker.com.
#LongCOVID #COVIDAntibodySpectrumTest #PersonalisedMedicine
The clinical rationale for this testing includes:
➡️ Identification of immunity gaps potentially associated with viral persistence, a significant factor in long COVID symptomatology.
#LongCOVID #COVIDAntibodySpectrumTest #PersonalisedMedicine
Attomarker remains focused on delivering precision diagnostics for individuals living with long COVID, regardless of their location. Our commitment to this area of unmet need continues.
#LongCOVID #GlobalHealth #Attomarker #COVIDAntibodySpectrumTest
The Attomarker COVID Antibody Spectrum Test is imminently launching in the USA. Work is underway to establish its availability.
#LongCOVID #COVIDAntibodySpectrumTest #USA #HealthInnovation #PrecisionDiagnostics